GSP of 6 pharmaceutical companies was cancelled and 1 was withdrawn

Today (August 2), the State Food and Drug Administration issued four consecutive announcements, announcing that six pharmaceutical companies had been revoked their GSP certificates, and were judged to be seriously dishonest; one company had been revoked their GSP certificates According to the statistics of the author, the following problems exist in the pharmaceutical enterprises whose GSP certificates have been withdrawn or withdrawn: 1 The enterprises do not engage in drug trading activities according to the approved contents; 2 The computer system of the enterprises does not realize the information transmission and data sharing between departments and posts; 3 The purchasing department of the enterprises fails to provide invoices; 4 The enterprises do not regularly review and revise the quality management documents; 5 Some drugs are not stored in the corresponding warehouse according to the temperature and humidity requirements; 6 Drugs and non drugs, external drugs and other drugs are not stored separately; 7 Drug maintenance personnel do not effectively monitor and control the temperature and humidity of the warehouse according to the storage conditions of drugs Attachment: list of pharmaceutical companies whose GSP certificate has been withdrawn / collected: Anhui Hongshun Pharmaceutical Co., Ltd GSP certificate has been withdrawn From June 30 to July 1, 2016, Anhui food and Drug Administration organized the supervision and inspection team to supervise and inspect Anhui Hongshun Pharmaceutical Co., Ltd in the form of flight inspection in accordance with the measures for flight inspection of pharmaceutical and medical devices (Order No 14 of the State Food and Drug Administration) The inspection found that the enterprise had violated the "quality management standards for drug trading" (Order No 13 of the State Food and Drug Administration) According to Article 40 of the measures for the administration of quality management standard certification of Pharmaceutical Trading (gsyj [2013] No 25) and the guiding principles of on-site inspection in Anhui Province (wsyjm [2014] No 237), through research, it is confirmed that the pharmaceutical trading behavior of the enterprise does not conform to the quality management standard of pharmaceutical trading, according to the measures for flight inspection of pharmaceutical medical devices and the measures for safety Anhui food and drug administration has withdrawn the above enterprise's certificate of quality management of drug distribution according to law, and is hereby notified List of pharmaceutical companies whose GSP certificate has been revoked: